Cerity Partners LLC Has $1.28 Million Holdings in Addus HomeCare Corporation (NASDAQ:ADUS)

Cerity Partners LLC decreased its stake in shares of Addus HomeCare Corporation (NASDAQ:ADUS - Free Report) by 84.1% during the first quarter, according to the company in its most recent filing with the SEC. The fund owned 12,891 shares of the company's stock after selling 68,374 shares during the period. Cerity Partners LLC owned 0.07% of Addus HomeCare worth $1,275,000 as of its most recent filing with the SEC.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in ADUS. Capital Research Global Investors acquired a new stake in Addus HomeCare in the 4th quarter valued at approximately $51,149,000. American Century Companies Inc. lifted its position in shares of Addus HomeCare by 695.8% in the 4th quarter. American Century Companies Inc. now owns 284,346 shares of the company's stock worth $35,643,000 after acquiring an additional 248,613 shares during the period. GAMMA Investing LLC lifted its position in shares of Addus HomeCare by 10,307.8% in the 1st quarter. GAMMA Investing LLC now owns 130,930 shares of the company's stock worth $12,948,000 after acquiring an additional 129,672 shares during the period. Bank of America Corp DE lifted its position in shares of Addus HomeCare by 273.6% in the 4th quarter. Bank of America Corp DE now owns 175,070 shares of the company's stock worth $21,945,000 after acquiring an additional 128,211 shares during the period. Finally, Principal Financial Group Inc. lifted its position in shares of Addus HomeCare by 18.3% in the 1st quarter. Principal Financial Group Inc. now owns 475,818 shares of the company's stock worth $47,054,000 after acquiring an additional 73,720 shares during the period. Institutional investors and hedge funds own 95.35% of the company's stock.

Wall Street Analysts Forecast Growth

A number of brokerages have commented on ADUS. Wall Street Zen upgraded Addus HomeCare from a "hold" rating to a "buy" rating in a research report on Sunday, June 29th. Macquarie restated an "outperform" rating and set a $133.00 target price on shares of Addus HomeCare in a research report on Tuesday, June 10th. Finally, JMP Securities restated a "market outperform" rating and set a $150.00 target price on shares of Addus HomeCare in a research report on Wednesday, July 16th. Seven investment analysts have rated the stock with a buy rating and two have assigned a strong buy rating to the company. Based on data from MarketBeat.com, Addus HomeCare presently has a consensus rating of "Buy" and a consensus target price of $142.57.

Insider Activity at Addus HomeCare

In other news, EVP Michael D. Wattenbarger sold 2,045 shares of Addus HomeCare stock in a transaction on Tuesday, May 27th. The stock was sold at an average price of $115.00, for a total value of $235,175.00. Following the completion of the sale, the executive vice president directly owned 7,796 shares of the company's stock, valued at approximately $896,540. This trade represents a 20.78% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Company insiders own 4.60% of the company's stock.

Addus HomeCare Price Performance

ADUS stock traded up $1.59 during midday trading on Friday, reaching $109.75. 48,705 shares of the company's stock traded hands, compared to its average volume of 189,950. The company has a 50-day simple moving average of $112.36 and a two-hundred day simple moving average of $109.56. Addus HomeCare Corporation has a 1-year low of $88.96 and a 1-year high of $136.72. The company has a market cap of $2.02 billion, a price-to-earnings ratio of 24.76, a PEG ratio of 1.56 and a beta of 0.81. The company has a quick ratio of 1.74, a current ratio of 1.74 and a debt-to-equity ratio of 0.20.

Addus HomeCare (NASDAQ:ADUS - Get Free Report) last released its quarterly earnings results on Monday, May 5th. The company reported $1.42 earnings per share for the quarter, beating analysts' consensus estimates of $1.33 by $0.09. The firm had revenue of $337.71 million during the quarter, compared to analysts' expectations of $341.66 million. Addus HomeCare had a return on equity of 9.23% and a net margin of 6.52%. The business's revenue was up 20.3% on a year-over-year basis. During the same period last year, the firm posted $1.21 EPS. On average, analysts anticipate that Addus HomeCare Corporation will post 4.59 earnings per share for the current year.

Addus HomeCare Company Profile

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.